Evaluating dose constraints for radiation induced liver damage following magnetic resonance image guided Stereotactic Body radiotherapy. (January 2021)

• Record Type: Journal Article
• Authors: Yadav, Poonam; Kuczmarska-Haas, Aleksandra; Musunuru, Hima Bindu; Witt, Jacob; Blitzer, Grace; Mahler, Peter; Bassetti, Michael F.
• Is Part Of: Physics and imaging in radiation oncology. Volume 17(2021)
• Page Start: 91
• Page End: 94
• Publication Date: 2021-01
• Subjects: Radiation induced liver damage -- MRI-guided radiotherapy -- SBRT; Radiotherapy -- Periodicals; Radiation dosimetry -- Periodicals; Cancer -- Imaging -- Periodicals; Oncology -- Periodicals; 615.842
• DOI: 10.1016/j.phro.2021.01.009
• Languages: English
• ISSNs: 2405-6316

Abstract

Abstract: This study reports dose corresponding to visible radiation induced liver damage following Stereotactic Body Radiation Therapy (SBRT) for liver metastasis, and the optimal time for follow up scans using post radiation imaging. Diagnostic magnetic resonance scans of nine patients treated with liver SBRT using a 0.35 T MRI-guided radiotherapy system were analyzed. The dice coefficients between the region of visible liver damage and the delivered dose were calculated. A median dose of 35 Gy correlated most closely with the visible radiation induced liver damage. We compared scans over two to nine months and observed maximal dice coefficients at two to five months post radiation. We have presented a new method for developing treatment planning guidelines for liver SBRT.